Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Ho

Showing results (61-70 of 241) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|September 7, 2022
Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir TreatmentMichael E Charness, Kalpana Gupta, Gary Stack, et al.
Journal of Virology|August 21, 2002
Compartmentalization of surface envelope glycoprotein of human immunodeficiency virus type 1 during acute and chronic infectionLinqi Zhang, Leslie Rowe, Tian He, et al.
Journal of Virology|October 29, 2003
Viral blip dynamics during highly active antiretroviral therapyMichele Di Mascio, Martin Markowitz, Michael Louie, et al.
Structure (London, England : 1993)|December 8, 2010
Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibodyMichael M Freeman, Michael S Seaman, Sophia Rits-Volloch, et al.
Plos One|September 16, 2008
A recoding method to improve the humoral immune response to an HIV DNA vaccineYaoxing Huang, Michael Krasnitz, Raul Rabadan, et al.
Infection and Immunity|April 3, 2013
Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile diseaseChandrabali Ghose, Janneke M Verhagen, Xinhua Chen, et al.
AIDS (London, England)|May 4, 2005
In vivo replication kinetics of a nef-deleted strain of HIV-1Suzanne M Crowe, David D Ho, Debbie Marriott, et al.
Cell Host & Microbe|February 20, 2024
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1Qian Wang, Yicheng Guo, Anthony Bowen, et al.
Structure (London, England : 1993)|January 30, 2025
Structure of a zoonotic H5N1 hemagglutinin reveals a receptor-binding site occupied by an auto-glycanNicholas C Morano, Yicheng Guo, Jordan E Becker, et al.
Lancet (London, England)|November 3, 2023
SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent boosterQian Wang, Anthony Bowen, Jerren Ho, et al.
Pageof 25

Showing results (61-70 of 241) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|September 7, 2022
Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir TreatmentMichael E Charness, Kalpana Gupta, Gary Stack, et al.
Journal of Virology|August 21, 2002
Compartmentalization of surface envelope glycoprotein of human immunodeficiency virus type 1 during acute and chronic infectionLinqi Zhang, Leslie Rowe, Tian He, et al.
Journal of Virology|October 29, 2003
Viral blip dynamics during highly active antiretroviral therapyMichele Di Mascio, Martin Markowitz, Michael Louie, et al.
Structure (London, England : 1993)|December 8, 2010
Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibodyMichael M Freeman, Michael S Seaman, Sophia Rits-Volloch, et al.
Plos One|September 16, 2008
A recoding method to improve the humoral immune response to an HIV DNA vaccineYaoxing Huang, Michael Krasnitz, Raul Rabadan, et al.
Infection and Immunity|April 3, 2013
Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile diseaseChandrabali Ghose, Janneke M Verhagen, Xinhua Chen, et al.
AIDS (London, England)|May 4, 2005
In vivo replication kinetics of a nef-deleted strain of HIV-1Suzanne M Crowe, David D Ho, Debbie Marriott, et al.
Cell Host & Microbe|February 20, 2024
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1Qian Wang, Yicheng Guo, Anthony Bowen, et al.
Structure (London, England : 1993)|January 30, 2025
Structure of a zoonotic H5N1 hemagglutinin reveals a receptor-binding site occupied by an auto-glycanNicholas C Morano, Yicheng Guo, Jordan E Becker, et al.
Lancet (London, England)|November 3, 2023
SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent boosterQian Wang, Anthony Bowen, Jerren Ho, et al.
Pageof 25